glp 1 weight loss success stories GLP-1 User Becomes ISSA-Certified to Sustain Man Who Bought 'Quick Fix'

It was first FDA-approved in 2022, also as a treatment for controlling blood sugar in people with type 2 diabetes

Weight Loss Results with Rybelsus: While not FDA-approved for weight loss, clinical trials showed: 3 mg dose: 1-2% body weight loss 7 mg dose: 2-3% body weight loss 14 mg dose: 3-5% body weight loss Compare to injectable semaglutide (Wegovy): 2.4 mg weekly injection: 10-15% body weight loss The difference: Injectable semaglutide produces 3-5 times more weight loss than oral semaglutide at maximum doses

Key facts: Weekly injection

Your health is your wealth take care of it by paying attention to key nutrients like glutathione

Kuro-o, M